IGMS
$6.75
Revenue | $0.65Mn |
Net Profits | $-60.7Mn |
Net Profit Margins | -9323.35% |
Igm Biosciences Inc’s revenue jumped 75% since last year same period to $0.65Mn in the Q4 2023. On a quarterly growth basis, Igm Biosciences Inc has generated 27.9% jump in its revenue since last 3-months.
Igm Biosciences Inc’s net profit fell -25.93% since last year same period to $-60.7Mn in the Q4 2023. On a quarterly growth basis, Igm Biosciences Inc has generated 2.09% jump in its net profits since last 3-months.
Igm Biosciences Inc’s net profit margin jumped 28.04% since last year same period to -9323.35% in the Q4 2023. On a quarterly growth basis, Igm Biosciences Inc has generated 23.44% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.83 |
EPS Estimate Current Year | -0.83 |
Igm Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.83 - a 19.42% jump from last quarter’s estimates.
Igm Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.83.
Earning Per Share (EPS) | -1.01 |
Return on Assets (ROA) | -0.35 |
Return on Equity (ROE) | -1 |
Igm Biosciences Inc’s earning per share (EPS) jumped 15.13% since last year same period to -1.01 in the Q4 2023. This indicates that the Igm Biosciences Inc has generated 15.13% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Igm Biosciences Inc’s return on assets (ROA) stands at -0.35.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Igm Biosciences Inc’s return on equity (ROE) stands at -1.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-03-07 | -1.03 | -1.01 | 1.94% |
2023-11-13 | -1.21 | -1.04 | 14.05% |
2023-08-03 | -1.43 | -1.43 | 0% |
2023-05-12 | -1.36 | -1.33 | 2.21% |